Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5W4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,688
Award facts
- Contract value 100% obligated
- $21,687.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,687.58 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. Entresto is a cardiovascular medication used in the treatment of heart failure, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing need to provision pharmaceutical products for military healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 31, 2031. This prime contract vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to support military healthcare programs globally. The competitively awarded structure of this delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements within the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FJ5W4?
SPE2DR26FJ5W4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FJ5W4 worth?
The government has obligated $21,688 on SPE2DR26FJ5W4.
Is contract SPE2DR26FJ5W4 an order under another contract?
Yes. SPE2DR26FJ5W4 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5W4 competed?
The extent of competition for SPE2DR26FJ5W4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award